304 related articles for article (PubMed ID: 20467470)
1. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.
Yap DY; Lai KN
J Biomed Biotechnol; 2010; 2010():365083. PubMed ID: 20467470
[TBL] [Abstract][Full Text] [Related]
2. [Cytokines in systemic lupus erythematosus].
Robak E; Sysa-Jedrzejowska A; Robak T
Przegl Lek; 1996; 53(8):623-6. PubMed ID: 8999465
[TBL] [Abstract][Full Text] [Related]
3. The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside.
Yap DY; Lai KN
Nephrology (Carlton); 2013 Apr; 18(4):243-55. PubMed ID: 23452295
[TBL] [Abstract][Full Text] [Related]
4. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
6. Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.
López-Pedrera C; Aguirre MÁ; Barbarroja N; Cuadrado MJ
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20936125
[TBL] [Abstract][Full Text] [Related]
7. Roles of IL-1 and IL-10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes?
Wu YR; Hsing CH; Chiu CJ; Huang HY; Hsu YH
IUBMB Life; 2022 Feb; 74(2):143-156. PubMed ID: 34668305
[TBL] [Abstract][Full Text] [Related]
8. Cytokines play a central role in the pathogenesis of systemic lupus erythematosus.
Singh AK
Med Hypotheses; 1992 Dec; 39(4):356-9. PubMed ID: 1494323
[TBL] [Abstract][Full Text] [Related]
9. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
[TBL] [Abstract][Full Text] [Related]
11. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus.
Cross JT; Benton HP
Inflamm Res; 1999 May; 48(5):255-61. PubMed ID: 10391113
[TBL] [Abstract][Full Text] [Related]
12. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
Robinson ES; Werth VP
Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.
Aringer M; Smolen JS
Lupus; 2004; 13(5):344-7. PubMed ID: 15230290
[TBL] [Abstract][Full Text] [Related]
14. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
15. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
16. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.
Thanou A; Stavrakis S; Dyer JW; Munroe ME; James JA; Merrill JT
Arthritis Res Ther; 2016 Sep; 18(1):197. PubMed ID: 27590046
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
[TBL] [Abstract][Full Text] [Related]
18. A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.
Bortoluzzi A; Vincenzi F; Govoni M; Padovan M; Ravani A; Borea PA; Varani K
Arthritis Res Ther; 2016 Aug; 18(1):192. PubMed ID: 27566294
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
[TBL] [Abstract][Full Text] [Related]
20. The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.
Goropevšek A; Holcar M; Avčin T
Clin Rev Allergy Immunol; 2017 Apr; 52(2):164-181. PubMed ID: 27216430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
